Jundishapur Journal of Microbiology
Ahvaz Jundishapur University of Medical Sciences
CrossRef
Works that cite this article, indexed by Crossref.
Effect of Prophylactic Vaccination with the Membrane-Bound Acid Phosphatase Gene of Leishmania mexicana in the Murine Model of Localized Cutaneous Leishmaniasis
Journal of Immunology Research 2021 (2021)
María Angélica Burgos-Reyes; Lidia Baylón-Pacheco; Patricia Espíritu-Gordillo; Silvia Galindo-Gómez; Víctor Tsutsumi; José Luis Rosales-Encina; Márcia Laurenti
Advances in Leishmania Vaccines: Current Development and Future Prospects
Pathogens 13(9) (2024)
Andreina Ayala; Alejandro Llanes; Ricardo Lleonart; Carlos M. Restrepo
Comparative Assessment of Induced Immune Responses Following Intramuscular Immunization with Fusion and Cocktail of LeIF, LACK and TSA Genes Against Cutaneous Leishmaniasis in BALB/c Mice
Archivum Immunologiae et Therapiae Experimentalis 66(1) (2018)
Nahid Maspi; Fatemeh Ghaffarifar; Zohreh Sharifi; Abdolhossein Dalimi; Mohammad Saaid Dayer
Leishmania vaccine development: A comprehensive review
Cellular Immunology 399-400 (2024)
Isha Saini; Jyoti Joshi; Sukhbir Kaur
Anti-mitochondrial Tryparedoxin Peroxidase Monoclonal Antibody-Based Immunohistochemistry for Diagnosis of Cutaneous Leishmaniasis
Frontiers in Microbiology 12 (2022)
Mariana Lourenço Freire; Felipe Dutra Rego; Karine Ferreira Lopes; Lucélia Antunes Coutinho; Rafaella Fortini Queiroz Grenfell; Daniel Moreira Avelar; Gláucia Cota; Marcelo Antônio Pascoal-Xavier; Edward Oliveira
Induction of immune responses by protein vaccines formulated with adjuvants against Leishmania major in vivo
Comparative Clinical Pathology 28(6) (2019)
Fatemeh Maleki; Mehdi Mahdavi; Somayeh Zarrati; Mehdi Shafiee Ardestani; Narges Khabazzade Tehrani; Abbas ali Imani fooladi; Fatemeh Tabatabaie
Vaccines for leishmaniasis and the implications of their development for American tegumentary leishmaniasis
Human Vaccines & Immunotherapeutics 16(4) (2020)
Beatriz Coutinho De Oliveira; Malcolm S. Duthie; Valéria Rêgo Alves Pereira
Alternative to Chemotherapy—The Unmet Demand against Leishmaniasis
Frontiers in Immunology 8 (2017)
Nicky Didwania; Md. Shadab; Abdus Sabur; Nahid Ali
Virulence factors of Leishmania parasite: Their paramount importance in unraveling novel vaccine candidates and therapeutic targets
Life Sciences 306 (2022)
Diksha Kumari; Shavi Mahajan; Parampreet Kour; Kuljit Singh
Immunogenicity and protective efficacy of a new Leishmania hypothetical protein applied as a DNA vaccine or in a recombinant form against Leishmania infantum infection
Molecular Immunology 106 (2019)
Patrícia A.F. Ribeiro; Daniel S. Dias; Daniela P. Lage; Vívian T. Martins; Lourena E. Costa; Thaís T.O. Santos; Fernanda F. Ramos; Grasiele S.V. Tavares; Débora V.C. Mendonça; Fernanda Ludolf; Dawidson A. Gomes; Michele A. Rodrigues; Miguel A. Chávez-Fumagalli; Eduardo S. Silva; Alexsandro S. Galdino; Mariana C. Duarte; Bruno M. Roatt; Daniel Menezes-Souza; Antonio L. Teixeira; Eduardo A.F. Coelho
Leishmaniasis Vaccine Development: A Review of Current Candidates and Cross-Species Protection Potential
Parasitologia 6(2) (2026)
Clara Yona; Amit Kumar Dey; Eva Moshiro; Abel Lupala; Magreth Macha
Immunogenicity and efficacy of a bivalent DNA vaccine containing LeIF and TSA genes against murine cutaneous leishmaniasis
APMIS 125(3) (2017)
Nahid Maspi; Fatemeh Ghaffarifar; Zohreh Sharifi; Abdolhossein Dalimi; Mohammad Saaid Dayer